This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Rachel Liberman: Innovator in Biochemical Detection
Introduction
Rachel Liberman is a prominent inventor based in Boston, MA. She has made significant contributions to the field of biochemical detection, particularly through her innovative methods for measuring UDP-glucose in biological samples. Her work is essential for advancing clinical laboratory practices.
Latest Patents
Rachel holds a patent for "Assays and methods for detecting UDP-glucose." This patent discloses methods, assays, compositions, and kits designed for the detection and measurement of UDP-glucose in biological samples. The techniques she developed are suitable for use with readily available clinical laboratory equipment, allowing for rapid and reproducible detection at physiologically relevant levels.
Career Highlights
Rachel is affiliated with The General Hospital Corporation, where she applies her expertise in biochemical research. Her work has been instrumental in enhancing the accuracy and efficiency of biochemical assays in clinical settings.
Collaborations
Rachel has collaborated with notable colleagues, including Sylvie Breton and Leileata M Russo. These partnerships have furthered her research and contributed to the development of innovative detection methods.
Conclusion
Rachel Liberman's contributions to the field of biochemical detection exemplify her dedication to innovation and research. Her patent for detecting UDP-glucose is a testament to her impact on clinical laboratory practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile